FTXNX
Price
$37.60
Change
-$3.55 (-8.63%)
Updated
Apr 3 closing price
Net Assets
2.47B
WCMNX
Price
$10.66
Change
-$0.85 (-7.38%)
Updated
Apr 3 closing price
Net Assets
41.58M
Ad is loading...

FTXNX vs WCMNX

Header iconFTXNX vs WCMNX Comparison
Open Charts FTXNX vs WCMNXBanner chart's image
FullerThaler Behavioral Sm-Cp Gr I
Price$37.60
Change-$3.55 (-8.63%)
VolumeN/A
Net Assets2.47B
WCM Small Cap Growth Investor
Price$10.66
Change-$0.85 (-7.38%)
VolumeN/A
Net Assets41.58M
FTXNX vs WCMNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FTXNX vs. WCMNX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTXNX is a Hold and WCMNX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FTXNX has more cash in the bank: 2.47B vs. WCMNX (41.6M). FTXNX (0.00) and WCMNX (0.00) have matching dividends . FTXNX was incepted earlier than WCMNX: FTXNX (7 years) vs WCMNX (5 years). WCMNX (2.11) is less costly to investors than FTXNX (1.36). FTXNX is a more actively managed with annual turnover of: 82.00 vs. WCMNX (48.00). FTXNX (1000) and WCMNX (1000) have matching initial minimum investment requirements. FTXNX annual gain was more profitable for investors over the last year : -3.45 vs. WCMNX (-10.22). FTXNX return over 5 years is better than : 147.74 vs. WCMNX (60.98).
FTXNXWCMNXFTXNX / WCMNX
Total Expense Ratio1.291.24104%
Annual Report Gross Expense Ratio1.362.1164%
Fund Existence7 years5 years-
Gain YTD-12.166-9.299131%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.47B41.6M5,930%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.45-10.2234%
Returns for 3 years24.92-7.10-351%
Returns for 5 years147.7460.98242%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTCX19.73N/A
N/A
Fidelity Advisor Biotechnology C
ASERX102.08N/A
N/A
American Century Select R
TMCAX11.60N/A
N/A
RBC SMID Cap Growth A
DGEZX12.67N/A
N/A
Destinations Equity Income Z
BSMDX12.22N/A
N/A
BlackRock SMID-Cap Growth Equity Instl